Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Estrogen receptor (ER)-negative cancers have a poor prognosis, and few targeted therapies are available for their treatment. Our previous analyses have identified potential kinase targets critical for the growth of ER-negative, progesterone receptor (PR)-negative and HER2-negative, or “triple-negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazumdar, Abhijit, Poage, Graham M., Shepherd, Jonathan, Tsimelzon, Anna, Hartman, Zachary C., Den Hollander, Petra, Hill, Jamal, Zhang, Yun, Chang, Jenny, Hilsenbeck, Susan G., Fuqua, Suzanne, Kent Osborne, C., Mills, Gordon B., Brown, Powel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963453/
https://www.ncbi.nlm.nih.gov/pubmed/27393618
http://dx.doi.org/10.1007/s10549-016-3892-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963453/
https://www.ncbi.nlm.nih.gov/pubmed/27393618
http://dx.doi.org/10.1007/s10549-016-3892-y

Ejemplares similares